ULIPRISTAL ACETATE
| Brand name | ELLA |
|---|---|
| Active ingredient | ULIPRISTAL ACETATE |
| Strength | 30MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | August 2010 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8426392 | June 2030 | use U-1389 |
| 8962603 | June 2030 | use U-1657 |
| 8512745 | June 2030 | product |
| 10159681 | April 2030 | use U-2510 |
| 10772897 | April 2030 | use U-2958 |
| 9283233 | April 2030 | use U-1821 |
| 8735380 | February 2029 | product |
| 9844510 | December 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.